External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease

Sponsor
University Hospital Inselspital, Berne (Other)
Overall Status
Completed
CT.gov ID
NCT00414297
Collaborator
(none)
30
1
2
34
0.9

Study Details

Study Description

Brief Summary

The purpose of this study in humans with stable coronary artery disease (CAD) treatable by percutaneous coronary intervention (PCI) is to evaluate the efficacy of External Counterpulsation (ECP) with regard to the promotion of coronary collateral growth.

Condition or Disease Intervention/Treatment Phase
  • Device: ECP Therapy
N/A

Detailed Description

Alternative strategies for the promotion of coronary collaterals (arteriogenesis) are a promising therapeutic alternative for at least 20% of all Patients with Coronary Artery Disease (CAD). Beside growth factors, physical exercise has been shown to improve coronary collateral function. Extracorporal Counterpulsation (ECP) mimics physical exercise in a standardized way. Before and after ECP treatment, a quantitative invasive assessment of absolute collateral flow (by calculating the CFI, i.e. Collateral Flow Index) and myocardial perfusion is performed (with calculation of the CPI, i.e. Collateral Perfusion Index and MPR, i.e. Myocardial Perfusion Reserve).

The study setting is single-blinded, sham-controlled and proceptive .

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
External Counterpulsation (ECP) for the Promotion of Collateral Growth in Patients With Coronary Artery Disease
Study Start Date :
Aug 1, 2006
Actual Primary Completion Date :
Dec 1, 2008
Actual Study Completion Date :
Jun 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1 ECP

active ECP Therapy

Device: ECP Therapy
application of ECP Therapy to CAD Patients

Placebo Comparator: 2

Sham ECP Treatment

Device: ECP Therapy
application of ECP Therapy to CAD Patients

Outcome Measures

Primary Outcome Measures

  1. Collateral flow index (CFI) [21 days]

  2. Coronary collateral resistance (Rcoll) [21 days]

Secondary Outcome Measures

  1. Myocardial perfusion reserve [21 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age > 18 years old

  • 1- to 3-vessel coronary artery disease (CAD)

  • Stable angina pectoris

  • At least 1 stenotic lesion suitable for PCI within the next 4 weeks

  • No Q-wave myocardial infarction in the area undergoing CFI measurement

  • Written informed consent to participate in the study

Exclusion Criteria:
  • Patients admitted as emergencies

  • Acute myocardial infarction within the last 3 months

  • Unstable CAD

  • CAD treated best by CABG

  • Coronary stenotic lesion to be treated ad-hoc or within < 4 weeks

  • Severe valve disease

  • Pulmonary artery hypertension

  • Congestive heart failure

  • Atrial fibrillation

  • Thrombophlebitis and/or deep vein thrombosis

  • Occlusive peripheral artery disease

  • Abdominal aortic aneurysm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bern University Hospital Bern Switzerland 3010

Sponsors and Collaborators

  • University Hospital Inselspital, Berne

Investigators

  • Study Chair: Christian Seiler, MD, Prof., University of Bern
  • Principal Investigator: Steffen Gloekler, MD, University of Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00414297
Other Study ID Numbers:
  • 61/06
First Posted:
Dec 21, 2006
Last Update Posted:
Oct 26, 2010
Last Verified:
Oct 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2010